Innate Pharma (IPHA) Accounts Payables (2017 - 2026)
Innate Pharma (IPHA) reported Accounts Payables of $13.1 million for the quarter ended Jun 30, 2026, down 3.9% from $13.63 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Accounts Payables (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Accounts Payables of $16.99 million, down 1.9% from the prior year.
- Accounts Payables has declined for seven consecutive years, with a five-year compound annual growth rate of -12.8% (years ended Dec 2020 to Dec 2025).
- By year, Accounts Payables came in at $17.32 million in the year ended Dec 31, 2024 (-5.9%), $18.41 million in the year ended Dec 31, 2023 (-16.5%), $22.04 million in the year ended Dec 31, 2022 (-32.6%) and $32.69 million in the year ended Dec 31, 2021 (-3.1%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Accounts Payables in data going back to the quarter ended Dec 31, 2017.
- Year over year, Accounts Payables gained in 1 of the last four quarters, with an average decline of 7.1%.
- The high point for year-over-year Accounts Payables in five years was the quarter ended Jun 30, 2023 (growth of 3.8%); the low point was the quarter ended Dec 31, 2022 (a decline of 34.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | 13.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.10 Mn |
| Dec 31, 2025 | 17.51 Mn |
| Jun 30, 2025 | 13.63 Mn |
| Dec 31, 2024 | 17.11 Mn |
| Jun 30, 2024 | 17.09 Mn |
| Dec 31, 2023 | 18.31 Mn |
| Jun 30, 2023 | 20.68 Mn |
| Dec 31, 2022 | 21.33 Mn |
| Jun 30, 2022 | 19.92 Mn |
| Dec 31, 2021 | 32.69 Mn |
| Jun 30, 2021 | 20.50 Mn |
| Dec 31, 2020 | 35.22 Mn |
| Jun 30, 2020 | 26.54 Mn |
| Dec 31, 2019 | 54.80 Mn |
| Dec 31, 2018 | 104.61 Mn |
| Dec 31, 2017 | 29.03 Mn |
API Access
Innate Pharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();